Section 1: Medicinal products in lists I and II, narcotic and psychotropic medicinal products, and substances used in the preparation of medicinal products

By way of derogation from Article R. 5121-138, the label, printed by the pharmacist at the time of dispensing and affixed to the new outer packaging referred to in Article R. 5132-42-4, shall bear the following information, written in such a way as to be easily legible, clearly understandable and indelible: 1° The name of the proprietary medicinal product, the strength and the pharmaceutical form ; 2° Where appropriate, a…

When dispensing a medicinal product by unit, the pharmacist provides the patient with a printed version of the package leaflet referred to in Article R. 5121-148. By way of derogation from the previous paragraph, he may, subject to the patient’s agreement, inform the patient by any means of the arrangements for access to the electronic version of the package leaflet for the medicinal product in question.